Copeland-Halperin RS - Search Results

1

Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer.

Copeland-Halperin RS, Al-Sadawi M, Patil S, Liu JE, Steingart RM, Dang CT, Yu AF. Copeland-Halperin RS, et al. JAMA Oncol. 2020 Dec 1;6(12):1971-1972. doi: 10.1001/jamaoncol.2020.4749. JAMA Oncol. 2020. PMID: 33057570 Free PMC article.

2

Racial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer.

Al-Sadawi M, Hussain Y, Copeland-Halperin RS, Tobin JN, Moskowitz CS, Dang CT, Liu JE, Steingart RM, Johnson MN, Yu AF. Al-Sadawi M, et al. Among authors: copeland halperin rs. Am J Cardiol. 2021 May 15;147:116-121. doi: 10.1016/j.amjcard.2021.02.013. Epub 2021 Feb 20. Am J Cardiol. 2021. PMID: 33617819 Free PMC article.

3

Cardiotoxicity of HER2-targeted therapies.

Copeland-Halperin RS, Liu JE, Yu AF. Copeland-Halperin RS, et al. Curr Opin Cardiol. 2019 Jul;34(4):451-458. doi: 10.1097/HCO.0000000000000637. Curr Opin Cardiol. 2019. PMID: 31082851 Free PMC article. Review.

4

Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences.

Hirsh BJ, Copeland-Halperin RS, Halperin JL. Hirsh BJ, et al. Among authors: copeland halperin rs. J Am Coll Cardiol. 2015 May 26;65(20):2239-51. doi: 10.1016/j.jacc.2015.03.557. J Am Coll Cardiol. 2015. PMID: 25998669 Free article. Review.

5

Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry.

Copeland-Halperin RS, Baber U, Aquino M, Rajamanickam A, Roy S, Hasan C, Barman N, Kovacic JC, Moreno P, Krishnan P, Sweeny JM, Mehran R, Dangas G, Kini AS, Sharma SK. Copeland-Halperin RS, et al. Catheter Cardiovasc Interv. 2018 Apr 1;91(5):859-866. doi: 10.1002/ccd.27204. Epub 2017 Jul 19. Catheter Cardiovasc Interv. 2018. PMID: 28722295

6

Aiming at strategies for a complex problem of medical nonadherence.

Castellano JM, Copeland-Halperin R, Fuster V. Castellano JM, et al. Glob Heart. 2013 Sep;8(3):263-71. doi: 10.1016/j.gheart.2013.06.001. Epub 2013 Sep 26. Glob Heart. 2013. PMID: 25690505 Free article.

7

The effect of salsalate therapy on endothelial function in a broad range of subjects.

Nohria A, Kinlay S, Buck JS, Redline W, Copeland-Halperin R, Kim S, Beckman JA. Nohria A, et al. J Am Heart Assoc. 2014 Jan 3;3(1):e000609. doi: 10.1161/JAHA.113.000609. J Am Heart Assoc. 2014. PMID: 24390146 Free PMC article. Clinical Trial.

8

Impaired skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in patients with peripheral artery disease and intermittent claudication.

Pande RL, Park MA, Perlstein TS, Desai AS, Doyle J, Navarrete N, Copeland-Halperin RS, Redline W, Di Carli MF, Creager MA. Pande RL, et al. Among authors: copeland halperin rs. Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):190-6. doi: 10.1161/ATVBAHA.110.217687. Epub 2010 Nov 4. Arterioscler Thromb Vasc Biol. 2011. PMID: 21051665

9

Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.

Attieh RM, Nunez B, Copeland-Halperin RS, Jhaveri KD. Attieh RM, et al. Among authors: copeland halperin rs. Cardiorenal Med. 2024;14(1):281-293. doi: 10.1159/000539075. Epub 2024 Apr 29. Cardiorenal Med. 2024. PMID: 38684145 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters